• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青光眼和年龄相关性黄斑变性患者中的疾病关联。

Disease Associations among Patients Afflicted with Both Glaucoma and Age-Related Macular Degeneration.

作者信息

Dimalanta Lauren, Pithadia Kishan, Shenkute Nathan T, Strelow Bryan, Zhang Zhidong, Ulrich Jan, Zhang Alice Y, Fleischman David

机构信息

Department of Ophthalmology, University of North Carolina, Chapel Hill, NC 27514, USA.

Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.

出版信息

J Clin Med. 2024 Oct 6;13(19):5941. doi: 10.3390/jcm13195941.

DOI:10.3390/jcm13195941
PMID:39408001
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11478099/
Abstract

: This study investigates whether there is an increased propensity to systemic conditions in patients with both age-related macular degeneration (AMD) and glaucoma in order to provide greater insight into patients' overall health and response to physiologic stress. : A large retrospective dataset review was conducted between April 2004 and June 2018, distinguishing four groups based on international classification of diseases (ICD) codes: glaucoma only, AMD only, glaucoma and AMD, and cataracts only (as an age-matched control). The systemic disease prevalence of each group was calculated, and a Friedman analysis was used to compare the prevalence between the groups. : This study identified 5243 patients with glaucoma only, 6726 with AMD only, 402 with combined disease, and 25,450 with cataracts only. Age and racial distributions varied between groups in a predictable manner. Two conditions, heart failure (HF) and dementia, had a statistically higher prevalence in patients with both glaucoma and AMD compared to those with glaucoma alone (HF = 0.036, dementia = 0.024) and cataracts alone (HF = 0.003, dementia = 0.036). There was no significant difference observed in terms of ethnicity and gender among the different disease groups ( > 0.05). : Both AMD and glaucoma individually portend a higher rate of comorbidities than age-matched controls. Patients with concomitant AMD and glaucoma demonstrate a uniquely higher prevalence of heart failure and dementia than those with either disease alone. The underlying association and pathologic mechanisms warrant further investigation to improve the overall health management and prognostication for these individuals.

摘要

本研究调查年龄相关性黄斑变性(AMD)和青光眼患者发生全身性疾病的倾向是否增加,以便更深入了解患者的整体健康状况和对生理应激的反应。

在2004年4月至2018年6月期间进行了一项大型回顾性数据集审查,根据国际疾病分类(ICD)代码区分四组:仅青光眼组、仅AMD组、青光眼合并AMD组和仅白内障组(作为年龄匹配对照)。计算每组的全身性疾病患病率,并使用弗里德曼分析比较各组之间的患病率。

本研究确定了5243例仅患有青光眼的患者、6726例仅患有AMD的患者、402例患有合并疾病的患者以及25450例仅患有白内障的患者。各组之间的年龄和种族分布以可预测的方式有所不同。与仅患有青光眼的患者(心力衰竭[HF]=0.036,痴呆=0.024)和仅患有白内障的患者(HF=0.003,痴呆=0.036)相比,两种疾病(HF和痴呆)在患有青光眼和AMD的患者中的患病率在统计学上更高。不同疾病组之间在种族和性别方面未观察到显著差异(P>0.05)。

AMD和青光眼单独发生时的合并症发生率均高于年龄匹配对照。同时患有AMD和青光眼的患者心力衰竭和痴呆的患病率比仅患有其中一种疾病的患者显著更高。潜在的关联和病理机制值得进一步研究,以改善这些个体的整体健康管理和预后。

相似文献

1
Disease Associations among Patients Afflicted with Both Glaucoma and Age-Related Macular Degeneration.青光眼和年龄相关性黄斑变性患者中的疾病关联。
J Clin Med. 2024 Oct 6;13(19):5941. doi: 10.3390/jcm13195941.
2
Propensity-Matched Analysis of the Risk of Age-Related Macular Degeneration with Systemic Immune-Mediated Inflammatory Disease.基于倾向性评分匹配的系统性免疫介导的炎症性疾病与年龄相关性黄斑变性风险分析。
Ophthalmol Retina. 2024 Aug;8(8):778-785. doi: 10.1016/j.oret.2024.01.026. Epub 2024 Feb 4.
3
Risk, Prevalence, and Progression of Glaucoma in Eyes With Age-Related Macular Degeneration Treated With Intravitreal Anti-Vascular Endothelial Growth Factor Injections.抗血管内皮生长因子眼内注射治疗年龄相关性黄斑变性相关青光眼的风险、患病率和进展。
Am J Ophthalmol. 2022 Nov;243:98-108. doi: 10.1016/j.ajo.2022.07.025. Epub 2022 Aug 3.
4
Routine eye examinations for persons 20-64 years of age: an evidence-based analysis.20至64岁人群的常规眼部检查:一项基于证据的分析。
Ont Health Technol Assess Ser. 2006;6(15):1-81. Epub 2006 Jul 1.
5
Comparison of comorbid conditions between neovascular age-related macular degeneration patients and a control cohort in the medicare population.医疗保险人群中新血管性年龄相关性黄斑变性患者与对照队列之间共病情况的比较。
Retina. 2007 Nov-Dec;27(9):1292-9. doi: 10.1097/01.iae.0000300915.81866.b8.
6
Frequency of coexistent eye diseases and cognitive impairment or dementia: a systematic review and meta-analysis.共存眼病与认知障碍或痴呆的频率:系统评价和荟萃分析。
Eye (Lond). 2023 Oct;37(15):3128-3136. doi: 10.1038/s41433-023-02481-4. Epub 2023 Mar 15.
7
[Risk factors in age-related macular degeneration and glaucoma--own observations].[年龄相关性黄斑变性和青光眼的危险因素——个人观察]
Klin Oczna. 2008;110(10-12):370-4.
8
Association Between Age-Related Macular Degeneration and Risk of Heart Failure: A Population-Based Nested Case-Control Study.年龄相关性黄斑变性与心力衰竭风险的关联:基于人群的巢式病例对照研究。
J Am Heart Assoc. 2021 Aug 3;10(15):e020071. doi: 10.1161/JAHA.120.020071. Epub 2021 Jul 30.
9
Underdiagnosis of glaucoma in patients with exudative age-related macular degeneration.渗出性年龄相关性黄斑变性患者的青光眼漏诊。
Eye (Lond). 2021 Dec;35(12):3350-3357. doi: 10.1038/s41433-021-01417-0. Epub 2021 Feb 3.
10
NAD+ and Niacin Supplementation as Possible Treatments for Glaucoma and Age-Related Macular Degeneration: A Narrative Review.烟酰胺腺嘌呤二核苷酸(NAD+)和烟酸补充剂作为治疗青光眼和年龄相关性黄斑变性的可能方法:一种叙述性综述。
Nutrients. 2024 Aug 21;16(16):2795. doi: 10.3390/nu16162795.

本文引用的文献

1
Inflammation in Heart Failure-Future Perspectives.心力衰竭中的炎症——未来展望
J Clin Med. 2023 Dec 17;12(24):7738. doi: 10.3390/jcm12247738.
2
Heart failure with comorbid dementia: Association with clinical characteristics and outcomes.心力衰竭伴合并痴呆:与临床特征和结局的关系。
J Am Geriatr Soc. 2023 Oct;71(10):3172-3178. doi: 10.1111/jgs.18467. Epub 2023 Jun 12.
3
The central role of the NLRP3 inflammasome pathway in the pathogenesis of age-related diseases in the eye and the brain.NLRP3 炎性小体通路在眼和脑中与年龄相关疾病发病机制中的核心作用。
Ageing Res Rev. 2023 Jul;88:101954. doi: 10.1016/j.arr.2023.101954. Epub 2023 May 13.
4
Association Between Age-Related Macular Degeneration and Risk of Heart Failure: A Population-Based Nested Case-Control Study.年龄相关性黄斑变性与心力衰竭风险的关联:基于人群的巢式病例对照研究。
J Am Heart Assoc. 2021 Aug 3;10(15):e020071. doi: 10.1161/JAHA.120.020071. Epub 2021 Jul 30.
5
Inflammation in Glaucoma: From the back to the front of the eye, and beyond.青光眼的炎症:从眼睛的后部到前部,以及更远的地方。
Prog Retin Eye Res. 2021 Jul;83:100916. doi: 10.1016/j.preteyeres.2020.100916. Epub 2020 Oct 17.
6
The Role of Inflammation in Age-Related Macular Degeneration.炎症在年龄相关性黄斑变性中的作用。
Int J Biol Sci. 2020 Sep 23;16(15):2989-3001. doi: 10.7150/ijbs.49890. eCollection 2020.
7
Retinal Degeneration and Alzheimer's Disease: An Evolving Link.视网膜退化与老年痴呆症:正在演变的关联。
Int J Mol Sci. 2020 Oct 2;21(19):7290. doi: 10.3390/ijms21197290.
8
Benzoic acid derivative-modified chitosan-g-poly(N-isopropylacrylamide): Methoxylation effects and pharmacological treatments of Glaucoma-related neurodegeneration.苯甲酸衍生物修饰的壳聚糖-g-聚(N-异丙基丙烯酰胺):与青光眼相关的神经退行性病变的甲氧基化作用和药物治疗。
J Control Release. 2020 Jan 10;317:246-258. doi: 10.1016/j.jconrel.2019.11.038. Epub 2019 Nov 29.
9
Comorbidity of dementia and age-related macular degeneration calls for clinical awareness: a meta-analysis.痴呆症和年龄相关性黄斑变性的共病需要临床关注:一项荟萃分析。
Br J Ophthalmol. 2019 Dec;103(12):1777-1783. doi: 10.1136/bjophthalmol-2018-313277. Epub 2019 Apr 18.
10
Glaucoma: In Search of Better Neurotherapeutics.青光眼:寻求更好的神经治疗方法
Curr Neuropharmacol. 2018;16(7):902. doi: 10.2174/1570159X1607180712164222.